The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Preserving Public Trust: Accreditation and Human Research Participant Protection Programs
Rudder, Catherine (Executive Director, American Political Science Association). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.
Ryan, Stephen J. (Dean, Keck School of Medicine, University of Southern California). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.
Shalala, Donna. 2000. Sounding Board: Protecting Research Subjects—What Must Be Done. New England Journal of Medicine 343:808–810.
Shopes, Linda (Historian, Pennsylvania Historical and Museum Commission). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.
Snyderman, R., and Holmes E. W. 2000. Oversight Mechanisms for Clinical Research. Science 287:595–597.
Starr, Paul. 1982. Transformation of American Medicine: The Rise of a Sovereign Professionand the Making of a Vast Industry. New York: Basic Books.
Sugarman, J. 2000. The Role of Institutional Support in Protecting Human Research Subjects Academic Medicine 75:687–692.
Thompson, Larry. 1994. Correcting the Code: Inventing the Genetic Cure for the Human Body. New York: Simon and Schuster.
Tuskegee Syphilis Study Ad Hoc Advisory Panel. 1973. Final Report. Washington, DC: U.S. Department of Health, Education, and Welfare.
United States v. Karl Brandt et al. 1949. In: The Medical Case, Trials of War Criminals Before the Nuremberg MilitaryTribunals Under Control Council Law No. 10. Washington, DC: U.S. Government Printing Office.
U.S. House of Representatives, Committee on Veterans Affairs. 1999. Suspension of Medical Research at West Los Angeles and SepulvedaVA MedicalFacilities and Informed Consent and Patient Safety in VA MedicalResearch: Hearing of the Committee on Veterans Affairs. 106th Cong. April 21, 1999.
U.S. Senate, Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions. 2000. Gene Therapy: Is There Oversight for Patient Safety?: Hearing ofthe Subcommittee on Public Health,Committee on Health, Education, Labor, and Pensions. 106th Congress. February 2, 2000.
VA (U.S. Department of Veterans Affairs). 2000. Press Release: VA Raises Standard for Protecting Human Research Participants. [Online]. Available: http://www.va.gov/opa [accessed February 20, 2001].
Weiss, R. and Nelson, D. 1999, December 8. Methods Faulted in Fatal Gene Therapy. The Washington Post. p. A1.
World Medical Association. 1964. Declaration of Helsinki: Ethical Principles for Medical ResearchInvolving Human Subjects. Ferney-Voltaire, France: World Medical Association.
World Medical Association. 2000. Declaration of Helsinki: Ethical Principles for Medical ResearchInvolving Human Subjects, revised. Ferney-Voltaire, France: World Medical Association.
Young, Kenneth E., Chamber, Charles M., Kells, H. R., and Associates. 1983. Understanding Accreditation. San Francisco: Jossey-Bank, Inc.